Results 21 to 30 of about 56,095 (304)

Management of biological waste of patients after radionuclide therapy

Радиационная гигиена, 2022
Radioactive waste management is a modern-day issue in terms of radiation safety due to the development of radionuclide therapy, the emergence of new radiopharmaceuticals, radionuclides, and treatment methods, which allow for radionuclide therapy in a day
L. A. Chipiga, A. V. Vodovatov, I. A. Zvonova, A. A. Stanzhevsky, A. V. Petryakova, E. E. Anokina, K. S. Velichkina, S. A. Ryzhov   +7 more
doaj   +1 more source

Nephrotoxicity after radionuclide therapies

Translational Oncology, 2022
Radioligand therapies have opened new treatment avenues for cancer patients. They offer precise tumor targeting with a favorable efficacy-to-toxicity profile. Specifically, the kidneys, once regarded as the critical organ for radiation toxicity, also show excellent tolerance to radiation doses as high as 50-60 Gy in selected cases.
Vikas Prasad, Sejal Chopra, Ashwin Singh Parihar   +2 more
openaire   +4 more sources

Radionuclides for Targeted Therapy: Physical Properties

Molecules, 2022
A search in PubMed revealed that 72 radionuclides have been considered for molecular or functional targeted radionuclide therapy. As radionuclide therapies increase in number and variations, it is important to understand the role of the radionuclide and ...
Caroline Stokke, Monika Kvassheim, Johan Blakkisrud   +2 more
doaj   +1 more source

Development of the First Tritiated Tetrazine: Facilitating Tritiation of Proteins

ChemBioChem, Volume 23, Issue 23, December 5, 2022., 2022
A tritiated tetrazine based on a phenyl/pyridyl core structure was successfully radiolabeled with NaBT4 by reducing an aldehyde moiety. The synthon was effectively employed to label an antibody in vitro with pretargeted autoradiography. Abstract Tetrazine (Tz)–trans‐cyclooctene (TCO) ligation is an ultra‐fast and highly selective reaction and it is ...
Natasha Shalina Radjani Bidesi, Umberto Maria Battisti, Sara Lopes van de Broek, Vladimir Shalgunov, Anne‐Mette Dall, Jesper Bøggild Kristensen, Dag Sehlin, Stina Syvänen, Gitte Moos Knudsen, Matthias Manfred Herth   +9 more
wiley   +1 more source

Peptide Receptor Radionuclide Therapy

The Journal of Clinical Endocrinology & Metabolism, 2022
Abstract The concept of using a targeting molecule labeled with a diagnostic radionuclide for using positron emission tomography or single photon emission computed tomography imaging with the potential to demonstrate that tumoricidal radiation can be delivered to tumoral sites by administration of the same or a similar targeting molecule
Johannes Hofland, Tessa Brabander, Frederik A Verburg, Richard A Feelders, Wouter W de Herder   +4 more
openaire   +3 more sources

First communication on the efficacy of combined 177Lutetium-PSMA with immunotherapy outside prostate cancer

Journal for ImmunoTherapy of Cancer, 2022
Prostate-specific membrane antigen (PSMA)-targeted radioligand therapy is a validated treatment option for patients with advanced prostate cancer. Although PSMA expression is not limited to prostate tissue, little is known about its relevance to other ...
John Prior, Solange Peters, Krisztian Homicsko, Sarah Boughdad, Niklaus Schaefer, Antonia Digklia, Clarisse Dromain, Mounir Trimech, Ana Dolcan   +8 more
doaj   +1 more source

Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer

Pharmaceutics, 2021
In recent years, radionuclide therapy (RT) and targeted radionuclide therapy (TRT) have gained great interest in cancer treatment. This is due to promising results obtained in both preclinical and clinical studies.
Tyrillshall S. T. Damiana, Simone U. Dalm   +1 more
doaj   +1 more source

Hybrid Single-Photon Emission Computed Tomography/Computed Tomography Imaging Features of Tumoral Calcinosis in Technetium-99m Methylene Diphosphonate Bone Scintigraphy

World Journal of Nuclear Medicine, 2015
Tumoral calcinosis (TC) is an uncommon ectopic calcification syndrome. TC is a benign condition characterized by the presence of large calcific soft tissue deposits occurring predominantly in a periarticular location.
Koramadai Kamaleshwaran, Premkumar Asokumar, Anjali Malaikkal, Vyshakh Mohanan, Ajit Shinto   +4 more
doaj   +1 more source

Close contact restriction periods for patients who received iodine-131 therapy for differentiated thyroid cancer [PDF]

, 2022
Objective. Patients treated with radionuclide therapy may require restrictions on certain activities for a period of time following treatment to optimise protection of the public and ensure the legal dose limit is not exceeded. Software may be used to calculate necessary restriction periods for an individual based on longitudinal dose rate measurements
arxiv   +1 more source

Superficial radiation therapy for nonmelanoma skin cancer: A review

Dermatological Reviews, Volume 3, Issue 6, Page 409-417, December 2022., 2022
Abstract Background The high prevalence of nonmelanoma skin cancer (NMSC) has become a global health‐care burden. Various modalities have been established to treat NMSC, with surgery being the mainstay approach. Superficial radiation therapy (SRT) has been in use for over a century to treat various conditions. Recent discussion among the dermatological
Haowei Han, Anita Gade, Francesca M. Ceci, Alec Lawson, Sloane Auerbach, Mark S. Nestor   +5 more
wiley   +1 more source